I'm LongbridgeAI, I can summarize articles.CNBC traders highlighted four stocks: Eaton, SpaceX, AbbVie, and AMD. Eaton was selected due to Wells Fargo's Overweight rating; SpaceX for its Starship orbital launch; AbbVie following FDA approval of its Parkinson's drug Juvmo; and AMD based on a StoneX Buy recommendation. The segment also noted recent price movements for these equities.
On CNBC’s “Halftime Report Final Trades,” Joseph M. Terranova, senior managing director for Virtus Investment Partners, picked Eaton Corporation plc (NYSE:ETN).
Supporting his choice, Wells Fargo analyst Stephen Tusa initiated coverage on Eaton on Sept. 25 with an Overweight rating and a price target of $503.
Stephanie Link, chief investment strategist, head of investment solutions and equity portfolio manager at Hightower Advisors, said Space Exploration Technologies Corp. (NASDAQ:SPCX) is still down 26% from its highs.
In recent news, SpaceX announced that its launch vehicle Starship (designed to carry over 100 metric tons) took flight on Monday and reached orbit on Flight 14.
Don’t forget to check out our premarket coverage here
Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, named AbbVie Inc. (NYSE:ABBV) as his final trade.
On Friday, the U.S. Food and Drug Administration (FDA) approved AbbVie’s Juvmo (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for adults with Parkinson’s disease.
Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, recommended Advanced Micro Devices, Inc. (NASDAQ:AMD).
Supporting his view, StoneX analyst Cody Acree reiterated a Buy on Advanced Micro Devices on Tuesday and maintained a $685 price target.
Price Action
- Eaton shares gained 0.4% to close at $433.27 on Tuesday.
- SpaceX shares rose 2.6% to settle at $149.24 on Tuesday.
- AbbVie shares fell 1.1% to close at $263.29 during the session.
- AMD shares slipped 0.1% to settle at $607.57.
See More: Top Value Stocks
Photo via Shutterstock